CHLAMYDIA - ANVISA Registration 81816720075

Access comprehensive regulatory information for CHLAMYDIA in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 81816720075 and manufactured by VIRCELL S.L.. The registration is held by ALIFAX BRASIL COMER., EXP., IMP., DIST. DE EQUIPAMENTOS E REAGENTES PARA DIAGNOSTICO IN VITRO LTDA with validity until Sep 30, 2034.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG, VIRCELL S.L., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
81816720075
2 Related Devices
Registration Details
ANVISA Registration Number: 81816720075
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Related Devices (2)

CHLAMYDIA TRACHOMATIS VIRCLIA® IgA MONOTEST
Risk Class IV

Registration Details

81816720075

25351638522202324

31167508000102

Company Information

Dates and Status

Sep 30, 2024

30/09/2034

09/18/2025 19:00:01

CHLAMYDIA TRACHOMATIS VIRCLIA® IgA MONOTEST
Risk Class IV

Registration Details

81816720075

25351638522202324

31167508000102

Dates and Status

Sep 30, 2024

30/09/2034

09/18/2025 19:00:01